TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35415742

Group type: EXPERIMENTAL
Intervention: Paper-and-pencil-based cognitive training
Number of subjects: 81

Group type: COMPARATOR
Intervention: Standard rehabilitation care (Control)
Number of subjects: 81
Study: 33824890

Group type: EXPERIMENTAL
Intervention: SP-Lecturer group (n=28)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: RP-Tutor group (n=44)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 144
Study: 34786815

Group type: EXPERIMENTAL
Intervention: Intensive blood pressure control (< 120 mm Hg)
Number of subjects: 517

Group type: COMPARATOR
Intervention: Standard blood pressure control (< 140 mm Hg)
Number of subjects: 517
Study: 32718912

Group type: EXPERIMENTAL
Intervention: Aspirin 100 mg plus clopidogrel 75 mg daily
Number of subjects: 2590

Group type: COMPARATOR
Intervention: Aspirin 100 mg plus ticagrelor 90 mg twice daily
Number of subjects: 2590
Study: 34432358

Group type: EXPERIMENTAL
Intervention: Amlodipine
Number of subjects: 14

Group type: COMPARATOR
Intervention: Eplerenone
Number of subjects: 14
Study: 32384261

Group type: EXPERIMENTAL
Intervention: Short Foot Exercise (SFE)
Number of subjects: 3

Group type: COMPARATOR
Intervention: Towel-curl exercise
Number of subjects: 3
Study: 34330460

Group type: EXPERIMENTAL
Intervention: Vegan diet (intervention group, n = 122)
Number of subjects: 244

Group type: COMPARATOR
Intervention: Control group (n = 122)
Number of subjects: 244
Study: 32738349

Group type: COMPARATOR
Intervention: Full-mouth periodontal debridement (FMPD)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Methylene blue-assisted photodynamic therapy (PDT) with FMPD
Number of subjects: 26
Study: 35475696

Group type: EXPERIMENTAL
Intervention: Closed-loop systems
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Algorithm for diabetes care
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Automated insulin delivery systems
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Decision support systems
Number of subjects: 0
Study: 35300957

Group type: EXPERIMENTAL
Intervention: Piezosurgery
Number of subjects: 32

Group type: COMPARATOR
Intervention: Conventional Osteotomy
Number of subjects: 32
Study: 34534923

Group type: EXPERIMENTAL
Intervention: Liposomal bupivacaine 4 mg/kg via local infiltration at the end of spine surgery (age group 1)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Liposomal bupivacaine 4 mg/kg via local infiltration at the end of spine or cardiac surgery (age group 2)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Bupivacaine hydrochloride (HCl) 2 mg/kg via local infiltration at the end of spine surgery (age group 1)
Number of subjects: 65
Study: 34991769

Group type: EXPERIMENTAL
Intervention: Condition notification based on virtual reality technology
Number of subjects: 60

Group type: COMPARATOR
Intervention: Written explanations (Control)
Number of subjects: 60
Study: 32050911

Group type: EXPERIMENTAL
Intervention: Subjective norms and social support as measured by the Health Literacy Questionnaire and Control Preference Scale.
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Social support scores
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Alignment on decision-making roles
Number of subjects: 133
Study: 33094466

Group type: EXPERIMENTAL
Intervention: Intravenous high-dose vitamin C (3.0 g dissolved in 5% dextrose, 100 ml/time, 2 times/day)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Control group (routine therapy with intravenous drip of 5% dextrose and placebo, 100 ml/time, 2 times/day)
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Intravenous high-dose vitamin C
Number of subjects: 117

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 117
Study: 33065302

Group type: EXPERIMENTAL
Intervention: Tongue scraper, full mouth disinfection, and single application of PDT (Group II)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Tongue scraper and full mouth disinfection (Group I)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Single application of PDT (Group II)
Number of subjects: 40
Study: 35656983

Group type: EXPERIMENTAL
Intervention: High baseline neutrophil-to-lymphocyte ratio (NLR)
Number of subjects: 5881

Group type: EXPERIMENTAL
Intervention: Decrease in NLR between baseline and 1 year
Number of subjects: 5881
Study: 33602197

Group type: EXPERIMENTAL
Intervention: SRP using EGCG solution as coolant
Number of subjects: 20

Group type: COMPARATOR
Intervention: SRP using distilled water as coolant (Control)
Number of subjects: 20
Study: 33219056

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy
Number of subjects: 521

Group type: COMPARATOR
Intervention: No adjuvant chemotherapy
Number of subjects: 521
Study: 35270822

Group type: EXPERIMENTAL
Intervention: Teacher training in healthy eating and physical activity
Number of subjects: 7
Study: 33206194

Group type: EXPERIMENTAL
Intervention: Prenatal and predelivery models
Number of subjects: 502648

Group type: EXPERIMENTAL
Intervention: Delivery and postdelivery models
Number of subjects: 502648

Group type: EXPERIMENTAL
Intervention: Birth weight as a predictor
Number of subjects: 502648

Group type: EXPERIMENTAL
Intervention: Models incorporating 4 other top predictors
Number of subjects: 502648
Study: 34696030

Group type: EXPERIMENTAL
Intervention: Intermittent 10 min exposure/rest intervals during VR gaming
Number of subjects: 25

Group type: COMPARATOR
Intervention: Continuous VR gaming without breaks
Number of subjects: 25
Study: 32333328

Group type: EXPERIMENTAL
Intervention: Ibuprofen 400 mg/Caffeine 100 mg FDC
Number of subjects: 562

Group type: COMPARATOR
Intervention: Ibuprofen 400 mg
Number of subjects: 562

Group type: COMPARATOR
Intervention: Caffeine 100 mg
Number of subjects: 562

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 562
Study: 35363799

Group type: EXPERIMENTAL
Intervention: FOCUS (mindfulness-based stress management program)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Healthy Living (HL; active control)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Enhanced Care (EC; usual care)
Number of subjects: 0
Study: 33317988

Group type: EXPERIMENTAL
Intervention: QFT-GIT antigen tubes
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: QFT-plus tubes
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Nil tubes
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: IL-1RA in GIT Ag tubes
Number of subjects: 21
Study: 35299680

Group type: EXPERIMENTAL
Intervention: Karelizumab
Number of subjects: 100

Group type: COMPARATOR
Intervention: SRS
Number of subjects: 100
Study: 33951036

Group type: EXPERIMENTAL
Intervention: Clean delivery kits (CDKs) including gloves, cord clamps, plastic sheets, and razor blades.
Number of subjects: 36996
Study: 32611737

Group type: EXPERIMENTAL
Intervention: Methotrexate (MTX)
Number of subjects: 312

Group type: COMPARATOR
Intervention: Azathioprine (AZA)/6-mercaptopurine (6MP)
Number of subjects: 312

Group type: COMPARATOR
Intervention: Adalimumab (ADA)
Number of subjects: 312
Study: 36188432

Group type: EXPERIMENTAL
Intervention: S-1/temozolomide plus thalidomide
Number of subjects: 140

Group type: COMPARATOR
Intervention: S-1/temozolomide
Number of subjects: 140
Study: 35601970

Group type: EXPERIMENTAL
Intervention: Temozolomide (TMZ) administered in the morning (AM) before 10 am
Number of subjects: 35

Group type: COMPARATOR
Intervention: Temozolomide (TMZ) administered in the evening (PM) after 8 pm
Number of subjects: 35
Study: 32106713

Group type: EXPERIMENTAL
Intervention: Individualized follow-up with an app for one year
Number of subjects: 113

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 113
Study: 36335323

Group type: EXPERIMENTAL
Intervention: Intervention arm (OTCMS with interventions)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control arm (OTCMS without interventions)
Number of subjects: 12
Study: 32279919

Group type: EXPERIMENTAL
Intervention: HeartMate 3 (HM3)
Number of subjects: 927

Group type: EXPERIMENTAL
Intervention: HeartMate II (HMII)
Number of subjects: 927
Study: 33920642

Group type: EXPERIMENTAL
Intervention: Nasal steroid spray + BSE
Number of subjects: 47

Group type: COMPARATOR
Intervention: Nasal steroid spray + placebo tablet
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Saline nasal spray + BSE
Number of subjects: 47

Group type: COMPARATOR
Intervention: Saline nasal spray + placebo tablet
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Nasal corticosteroid + BSE
Number of subjects: 47
Study: 32406312

Group type: EXPERIMENTAL
Intervention: High sodium intake (3900 mg Na+/day)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (dextrose)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 20
Study: 36462139

Group type: EXPERIMENTAL
Intervention: High-supervision group (20 supervised sessions with an Exercise Professional over 12 weeks)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Low-supervision group (5 sessions over 12 weeks)
Number of subjects: 60
Study: 33419909

Group type: EXPERIMENTAL
Intervention: Ada app-based diagnostic tool
Number of subjects: 0

Group type: COMPARATOR
Intervention: Classical doctor-patient interaction
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Not specified
Number of subjects: 0
Study: 32473797

Group type: EXPERIMENTAL
Intervention: 10% potassium nitrate
Number of subjects: 43
Study: 35804491

Group type: EXPERIMENTAL
Intervention: Reconstructive surgery using bone substitute material
Number of subjects: 138

Group type: COMPARATOR
Intervention: Access flap surgery (control group)
Number of subjects: 138
Study: 33787169

Group type: EXPERIMENTAL
Intervention: Modular combined lower limb elastic compression device
Number of subjects: 40

Group type: COMPARATOR
Intervention: Modified Robert Jones bandage of 3M elastic bandage
Number of subjects: 40
Study: 33341180

Group type: EXPERIMENTAL
Intervention: Sexual risk reduction intervention
Number of subjects: 460

Group type: EXPERIMENTAL
Intervention: Sexual risk reduction intervention with alcohol content
Number of subjects: 460

Group type: EXPERIMENTAL
Intervention: Sexual risk reduction intervention with alcohol and cannabis content
Number of subjects: 460

Group type: COMPARATOR
Intervention: Historical, information-only, sexual risk reduction control arm
Number of subjects: 460
Study: 32040470

Group type: EXPERIMENTAL
Intervention: Detailed explanation about The Wand system
Number of subjects: 68

Group type: COMPARATOR
Intervention: No specific information about The Wand system (Control)
Number of subjects: 68
Study: 35652244

Group type: EXPERIMENTAL
Intervention: Infliximab
Number of subjects: 509

Group type: COMPARATOR
Intervention: SSZ + HCQ
Number of subjects: 509
Study: 33027800

Group type: EXPERIMENTAL
Intervention: Medical Nutrition Therapy (MNT) for 12 weeks, involving 6 appointments with registered dietitians.
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Medical Nutrition Therapy (MNT) group
Number of subjects: 130

Group type: COMPARATOR
Intervention: Control group (routine care)
Number of subjects: 130
Study: 35259767

Group type: EXPERIMENTAL
Intervention: Behavioral cardiac rehabilitation program (BCR)
Number of subjects: 249

Group type: COMPARATOR
Intervention: Conventional cardiac rehabilitation program (CCR)
Number of subjects: 249
Study: 32603531

Group type: EXPERIMENTAL
Intervention: Febuxostat (FBX)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Hydroxychloroquine (HCQ)
Number of subjects: 60
Study: 35761769

Group type: EXPERIMENTAL
Intervention: Permanent SCS (Perm group)
Number of subjects: 176

Group type: COMPARATOR
Intervention: Temporary SCS (Temp group)
Number of subjects: 176
Study: 33349509

Group type: EXPERIMENTAL
Intervention: Platelet-rich fibrin group (PRFG)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Bone marrow aspirate concentrate combined with platelet-rich fibrin group (BM/PG)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 15
Study: 35705150

Group type: EXPERIMENTAL
Intervention: Liberal fluid intake
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fluid restriction (1500 mL/day)
Number of subjects: 0
Study: 34272412

Group type: EXPERIMENTAL
Intervention: Genetically predicted atrial fibrillation (AF)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Genetically determined resting heart rate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: P-wave terminal force in the precordial lead V1 (PTFVI)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: P-wave duration (PWD)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: N-terminal pro-brain natriuretic peptide (NT-pro BNP)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PR interval
Number of subjects: 0
Study: 35886296

Group type: EXPERIMENTAL
Intervention: Cognitive intervention
Number of subjects: 150

Group type: COMPARATOR
Intervention: Sham cognitive intervention
Number of subjects: 150

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 150
Study: 34593721

Group type: EXPERIMENTAL
Intervention: Individualized educational program (educational booklet + biweekly personalized counseling)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control group (educational booklet only)
Number of subjects: 43
Study: 35473848

Group type: EXPERIMENTAL
Intervention: Informational videos (n=35)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Non-informational videos (n=27)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Videos uploaded by professionals (n=54)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Videos uploaded by non-professionals (n=8)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Overall videos analyzed (n=62)
Number of subjects: 62
Study: 33714860

Group type: EXPERIMENTAL
Intervention: SOX (100 mg/m2 of oxaliplatin on day 1 and 80 mg/m2/day of S‐1 on days 1‐14, every 21 days, eight cycles)
Number of subjects: 955

Group type: COMPARATOR
Intervention: UFT/LV (300 mg/m2 of UFT and 75 mg/day of LV on days 1‐28, every 35 days, five cycles)
Number of subjects: 955

Group type: EXPERIMENTAL
Intervention: SOX (in subgroup analysis for T4N2b disease)
Number of subjects: 955

Group type: COMPARATOR
Intervention: UFT/LV (in subgroup analysis for T4N2b disease)
Number of subjects: 955
Study: 32219623

Group type: EXPERIMENTAL
Intervention: MAKS treatment
Number of subjects: 433
Study: 35753684

Group type: EXPERIMENTAL
Intervention: Low-frequency transcutaneous electric nerve stimulation (LF-TENS)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Sham device
Number of subjects: 160
Study: 34020641

Group type: EXPERIMENTAL
Intervention: 2–5 day corticosteroid regimen
Number of subjects: 632

Group type: COMPARATOR
Intervention: 14-day corticosteroid regimen
Number of subjects: 632
Study: 32175892

Group type: EXPERIMENTAL
Intervention: Center-edge angle (CEA) measurement
Number of subjects: 1596

Group type: EXPERIMENTAL
Intervention: Center-edge angle (CEA) measurement in males
Number of subjects: 1596

Group type: EXPERIMENTAL
Intervention: Center-edge angle (CEA) measurement in females
Number of subjects: 1596

Group type: EXPERIMENTAL
Intervention: Center-edge angle (CEA) measurement for right hips
Number of subjects: 1596

Group type: EXPERIMENTAL
Intervention: Center-edge angle (CEA) measurement for left hips
Number of subjects: 1596

Group type: EXPERIMENTAL
Intervention: Center-edge angle (CEA) limits for mild dysplasia
Number of subjects: 1596

Group type: EXPERIMENTAL
Intervention: Center-edge angle (CEA) limits for severe dysplasia
Number of subjects: 1596

Group type: EXPERIMENTAL
Intervention: Age-related increase in CEA values
Number of subjects: 1596
Study: 35751307

Group type: EXPERIMENTAL
Intervention: Lidocaine hydrochloride 2 mg/kg bolus dose
Number of subjects: 40

Group type: COMPARATOR
Intervention: 0.9% normal saline continuous intravenous infusion
Number of subjects: 40
Study: 32797700

Group type: EXPERIMENTAL
Intervention: Tracker needle switched on
Number of subjects: 40

Group type: COMPARATOR
Intervention: Tracker needle switched off
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Needle tip identification before injection
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Needle tip identification before advance of the needle
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Failure to identify the needle tip before injection
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Failure to quickly regain needle tip position when visibility was lost
Number of subjects: 40
Study: 36068075

Group type: EXPERIMENTAL
Intervention: Guide group (computer-aided design and fully guided bone harvesting)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group (surgery without guide)
Number of subjects: 28
Study: 33305520

Group type: EXPERIMENTAL
Intervention: Starting the Conversation (STC) intervention - 20‐min video, workbook, and resource guide
Number of subjects: 144

Group type: COMPARATOR
Intervention: Control group - resource guide only
Number of subjects: 144
Study: 35233704

Group type: EXPERIMENTAL
Intervention: 1% NaOCl
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 2.5% NaOCl
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 5.25% NaOCl
Number of subjects: 40

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 40
Study: 34000964

Group type: EXPERIMENTAL
Intervention: Biofeedback (BFb)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control
Number of subjects: 32
Study: 34583659

Group type: EXPERIMENTAL
Intervention: Theory-based drug-use prevention program (10 sessions of 45 minutes each)
Number of subjects: 648

Group type: COMPARATOR
Intervention: Traditional didactic teaching and drug refusal skill training
Number of subjects: 648

Group type: EXPERIMENTAL
Intervention: Theory-based drug-use prevention program
Number of subjects: 648
Study: 32298326

Group type: EXPERIMENTAL
Intervention: 18-week exercise intervention during chemotherapy
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Baseline physical fatigue
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Baseline total PA
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Baseline leisure and sport PA
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Recreational facilities within a buffer of 1 km
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Physical fatigue at 4‐year follow‐up
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Change in physical fatigue during the intervention period
Number of subjects: 127
Study: 35770581

Group type: EXPERIMENTAL
Intervention: Exercise combined with Trigger Point Acupuncture (Ex+TrPAcp) for 3 months
Number of subjects: 15

Group type: COMPARATOR
Intervention: Exercise alone (Ex) for 3 months
Number of subjects: 15
Study: 34879820

Group type: EXPERIMENTAL
Intervention: STI risk prediction tool with a cut-point of 23
Number of subjects: 1007

Group type: EXPERIMENTAL
Intervention: STI risk prediction tool with a cut-point of 19
Number of subjects: 1007

Group type: EXPERIMENTAL
Intervention: CT/NG testing
Number of subjects: 1007

Group type: EXPERIMENTAL
Intervention: Risk factor questionnaire
Number of subjects: 1007
Study: 33563037

Group type: EXPERIMENTAL
Intervention: Brief educational intervention and contact program (BIC)
Number of subjects: 305

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 305

Group type: EXPERIMENTAL
Intervention: BIC
Number of subjects: 305

Group type: COMPARATOR
Intervention: TAU
Number of subjects: 305
Study: 33228736

Group type: EXPERIMENTAL
Intervention: Corticosteroids (monthly intravenous methylprednisolone pulses or daily oral prednisolone)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Clobazam (oral)
Number of subjects: 130
Study: 35848625

Group type: EXPERIMENTAL
Intervention: Mobile application in addition to standard management (short counseling session and 1-month course of oral iron therapy)
Number of subjects: 382

Group type: COMPARATOR
Intervention: Standard management (short counseling session and 1-month course of oral iron therapy)
Number of subjects: 382

Group type: EXPERIMENTAL
Intervention: Mobile application in addition to standard management
Number of subjects: 382

Group type: COMPARATOR
Intervention: Standard management
Number of subjects: 382
Study: 34236436

Group type: EXPERIMENTAL
Intervention: 1 g OBG (oat β-glucan) 3 times daily for 4 weeks
Number of subjects: 191

Group type: COMPARATOR
Intervention: Rice powder (Control)
Number of subjects: 191
Study: 32152488

Group type: EXPERIMENTAL
Intervention: Skin-to-skin care (SSC)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Oral sucrose
Number of subjects: 100
Study: 35697444

Group type: EXPERIMENTAL
Intervention: High egg and peanut diet (at least 6 eggs and 60 peanuts per week)
Number of subjects: 2136

Group type: COMPARATOR
Intervention: Standard (low) egg and peanut diet (no more than 3 eggs and 30 peanuts per week)
Number of subjects: 2136
Study: 35235030

Group type: EXPERIMENTAL
Intervention: Single injection IS nerve block of 10 cc (133 mg) liposomal bupivacaine mixed with 10 cc of 0.5% bupivacaine (Group 1)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Continuous indwelling IS nerve block catheter delivering 0.2% ropivacaine at a continual 4 cc/h infusion for the initial 3 post-operative days (Group 2)
Number of subjects: 76
Study: 34427188

Group type: EXPERIMENTAL
Intervention: Dietary self‐monitoring via MyFitnessPal for approximately 1 month
Number of subjects: 200

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 200
Study: 32679537

Group type: COMPARATOR
Intervention: Optimised usual care: information package and family doctor follow‐up 6 months postpartum
Number of subjects: 480

Group type: EXPERIMENTAL
Intervention: Brief intervention: information package plus assessment and brief LBC counselling at a specialised clinic with an obstetric physician and dietitian 6 months postpartum
Number of subjects: 480

Group type: EXPERIMENTAL
Intervention: Extended intervention: as per group 2 plus enrolment into a 6 month telephone‐based LBC program from 6 to 12 months postpartum
Number of subjects: 480
Study: 35150880

Group type: EXPERIMENTAL
Intervention: Intravenous posaconazole therapy followed by oral therapy (200 mg once daily after day 12)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Oral posaconazole therapy (400 mg twice daily on day 1, followed by 400 mg once daily)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Posaconazole unbound fraction
Number of subjects: 23
Study: 33052038

Group type: EXPERIMENTAL
Intervention: Robotic training (6 hours for ST group, 2 hours for MS group)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Robotic training
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Robotic training (MS group)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Laparoscopic training (6 hours for ST group, 2 hours for MS group)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Laparoscopic training
Number of subjects: 20

Group type: COMPARATOR
Intervention: Laparoscopic training (MS group)
Number of subjects: 20
Study: 34293446

Group type: EXPERIMENTAL
Intervention: Clofazimine with a median of 3 concomitant antibiotics
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Clofazimine
Number of subjects: 44